NCT02572089View on ClinicalTrials.gov

Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Drug OverdoseOpioid-Related Disorders
Interventions
DRUG

Naloxone

Trial Locations (1)

66212

Vince Associates Clinical Research, Overland Park

All Listed Sponsors
collaborator

Vince & Associates Clinical Research, Inc.

OTHER

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT02572089 - Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy Volunteers | Biotech Hunter | Biotech Hunter